logo image
search icon
Interventional Cardiology Devices Market

Interventional Cardiology Devices Market Size, Share & Trends Analysis Report By Product (Angioplasty Balloons, Angioplasty Stents, Structural Heart Devics, Catheters, Plaque Modification Devices, Hemodynamic Flow Alteration Devices Other Devices), By Region, And by Segment Forecasts, 2024-2031

Report ID : 2012 | Published : 2024-03-25 | Pages: 180 | Format: PDF/EXCEL

The Interventional Cardiology Devices Market Size is valued at USD 18.84 Bn in 2023 and is predicted to reach USD 33.91 Bn by the year 2031 at a 7.75% CAGR during the forecast period for 2024-2031. 

Interventional Cardiology Devices Market

Specialized tools are needed for interventional procedures to repair weak or damaged vessels, clogged arteries, or other impacted areas of the heart without surgery. Therefore, minimally invasive procedures are performed in hospitals or cardiac catheterization labs using interventional cardiology equipment such as coronary stents, cutting balloon catheters, and percutaneous transluminal coronary angioplasty (PTCA).

Cardiovascular diseases, like the coronary heart disease, stroke, and atrial fibrillation, are becoming more commonplace globally. The increase in biological risk factors, such as alcohol intake, bad food, cigarette use, and smoking, as well as environmental risk factors like pollution, are to blame for the increased prevalence of cardiovascular illnesses. The leading players' increasing product introductions are expected to boost the market for interventional cardiology devices.

Also, the significant occurance of cardiovascular conditions, comprising valvar defects and atrial stenosis, in developing regions like China, India, & Brazil has resulted in a strong need for interventional cardiology equipment. Major players are working together more and more to test a number of interventional devices in clinical studies. In March 2021, B. Braun SE and Infraredx collaborated to work an IDE clinical study for the drug coated PTCA balloon catheter SeQuent Please ReX.

Competitive Landscape

Some Major Key Players In The Interventional Cardiology Devices Market:

  • Medtronic
  • Boston Scientific Corporation
  • Abbott
  • Edward Lifescinces Corporation
  • Becton, Dickinson, and Company
  • B. Braun
  • Terumo Corporation
  • Biosensors International Group
  • Balton Sp. z o.o.
  • Biosensor International
  • Biotronik SE & Co. KG
  • Cardinal Health, Inc.
  • Comed B.V.
  • Endocor GmbH
  • iVascular S.L.U.
  • Johnson & Johnson
  • Koninklijke Philips N.V.
  • Medinol Ltd.
  • Penumbra, Inc.
  • Rontis AG
  • Scitech
  • SMT (Sahajanand Medical Technologies Pvt. Ltd.)
  • Stentys SA
  • WELLINQ
  • Lifetech Scientific

Market Segmentation:

The Interventional Cardiology Devices market is divided on the basis of Product. By Product the market is again divided into Angioplasty Balloons, Angioplasty Stents, Structural Heart Devics, Catheters, Plaque Modification Devices, Hemodynamic Flow Alteration Devices Other Devices. These subsegments are againd divided into more divisions. (Angioplasty Balloons is segmented into Old/Normal Balloons, Drug-eluting Balloons, Cutting and Scoring Balloons. Whereas Angioplasty Stents segement is divided into Drug-eluting Stents, Bare-metal Stents, Bioabsorbable Stents.

The Structural Heart Devics segment comprises Aortic Valve Therapy Devices, and Other Therapy Devices like Mitral valve, pulmonary valve and tricuspid valve & left atrial appendage therapy devices)). The Catheters segment includes Angiography Catheters, Guiding Catheters, and IVUS/OCT Catheters. Whereas, Plaque Modification Devices comprises Atherectomy Devices, and Thrombectomy Devices. At the end, Hemodynamic Flow Alteration Devices is divided into Embolic Protection Devices, & Chronic Total Occlusion Devices. Lastly Other Devices are Guidewires, Vascular Closure Devices, Introducer Sheaths, Hemostasis Valves, & Balloon Inflation Devices.

Based On Type, The Angioplasty Segments Are Accounted As A Major Contributor In The Interventional Cardiology Devices Market. 

Because coronary artery illnesses are so common, the sector for coronary vascular devices is expected to dominate. Because ballons and stents devices are becoming more common, structural cardiac devices are likewise predicted to have expanding growth prospects.

Embolic Protection Devices Witnessed Growth At A Rapid Rate

The embolic protection devices segment dominated the market for devices that alter the hemodynamic flow. This is due to the benefits of embolic protection devices over chronic total occlusion devices, such as the capacity to capture embolic detritus without interrupting continuous blood flow. In addition, the number of interventional procedures used to treat coronary artery disease is growing.

In The Region, The North American Interventional Cardiology Devices Market Holds A Significant Revenue Share.

The North America Interventional Cardiology Devices market is projected to get the highest revenue share in the near future. This is because North America is showing support a high rate of medical device innovation and has a high rate of using expensive interventional cardiology devices. It is the leader in the market under study. Some big market players in the area are also making new products and technologies to fight with products that are already on the market, while others are buying and working with other businesses that are popular in the market. 

Interventional Cardiology Devices Market Report Scope

Report Attribute

Specifications

Market Size Value In 2023

USD 18.84 Bn

Revenue Forecast In 2031

USD 33.91 Bn

Growth Rate CAGR

CAGR of 7.75% from 2024 to 2031

Quantitative Units

Representation of revenue in US$ Bn, Volume (No.of Units) and CAGR from 2024t o 2031

Historic Year

2019 to 2023

Forecast Year

2024-2031

Report Coverage

The forecast of revenue, the position of the company, the competitive market structure, growth prospects, and trends

Segments Covered

By Product

Regional Scope

North America; Europe; Asia Pacific; Latin America; Middle East & Africa

Country Scope

U.S.; Canada; U.K.; Germany; China; India; Japan; Brazil; Mexico; The UK; France; Italy; Spain; China; Japan; India; South Korea; South East Asia; South Korea; South East Asia

Competitive Landscape

Medtronic (US), Boston Scientific Corporation (US), Abbott (US), Edward Lifescinces Corporation (US), Cardinal Health (US), iVascular (Spain), Becton, Dickinson, and Company (US), B. Braun Melsungen (Germany), Terumo Corporation (Japan), Biosensors International Group (Singapore), and BIOTRONIK SE & Co. KG (Germany)

Customization Scope

Free customization report with the procurement of the report, Modifications to the regional and segment scope. Particular Geographic competitive landscape.

Pricing And Available Payment Methods

Explore pricing alternatives that are customized to your particular study requirements.

 

Chapter 1. Methodology and Scope

1.1. Research Methodology
1.2. Research Scope & Assumptions

Chapter 2. Executive Summary

Chapter 3. Global Interventional Cardiology Devices Market Snapshot

Chapter 4. Global Interventional Cardiology Devices Market Variables, Trends & Scope

4.1. Market Segmentation & Scope
4.2. Drivers
4.3. Challenges
4.4. Trends
4.5. Investment and Funding Analysis
4.6. Industry Analysis – Porter’s Five Forces Analysis
4.7. COVID-19 Impact Analysis

Chapter 5. Market Segmentation 1: By Technology Estimates & Trend Analysis
5.1. By Technology & Market Share, 2023-2031
5.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2019 to 2031 for the following By Technology:

5.2.1. Angioplasty Balloons

5.2.1.1. Old/Normal Balloons
5.2.1.2. Drug-eluting Balloons
5.2.1.3. Cutting and Scoring Balloons

5.2.2. Angioplasty Stents

5.2.2.1. Drug-eluting Stents
5.2.2.2. Bare-metal Stents
5.2.2.3. Bioabsorbable Stents

5.2.3. Structural Heart Devics

5.2.3.1. Aortic Valve Therapy Devices
5.2.3.2. Other Therapy Devices

5.2.4. Catheters

5.2.4.1. Angiography Catheters
5.2.4.2. Guiding Catheters
5.2.4.3. IVUS/OCT Catheters

5.2.5. Plaque Modification Devices

5.2.5.1. Atherectomy Devices
5.2.5.2. Thrombectomy Devices

5.2.6. Hemodynamic Flow Alteration Devices

5.2.6.1. Embolic Protection Devices
5.2.6.2. Chronic Total Occlusion Devices

5.2.7. Other Devices

5.2.7.1. Guidewires
5.2.7.2. Vascular Closure Devices
5.2.7.3. Introducer Sheaths
5.2.7.4. Hemostasis Valves
5.2.7.5. Balloon Inflation Devices

 
Chapter 6. Interventional Cardiology Devices Market Segmentation 2: Regional Estimates & Trend Analysis

6.1. North America

6.1.1. North America Interventional Cardiology Devices Market revenue (US$ Million) estimates and forecasts By Technology, 2019-2031
6.1.2. North America Interventional Cardiology Devices Market revenue (US$ Million) estimates and forecasts by country, 2019-2031
6.1.2.1. U.S.
6.1.2.2. Canada


6.2. Europe

6.2.1. Europe Interventional Cardiology Devices Market revenue (US$ Million) by Technology, 2019-2031
6.2.2. Europe Interventional Cardiology Devices Market revenue (US$ Million) by country, 2019-2031
6.2.2.1. Germany
6.2.2.2. Poland
6.2.2.3. France
6.2.2.4. Italy
6.2.2.5. Spain
6.2.2.6. UK
6.2.2.7. Rest of Europe


6.3. Asia Pacific

6.3.1. Asia Pacific Interventional Cardiology Devices Market revenue (US$ Million) by Technology, 2019-2031
6.3.2. Asia Pacific Interventional Cardiology Devices Market revenue (US$ Million) by country, 2019-2031
6.3.2.1. China
6.3.2.2. India
6.3.2.3. Japan
6.3.2.4. Australia
6.3.2.5. Rest of Asia Pacific


6.4. Latin America

6.4.1. Latin America Interventional Cardiology Devices Market revenue (US$ Million) by Technology, 2019-2031
6.4.2. Latin America Interventional Cardiology Devices Market revenue (US$ Million) by country, (US$ Million) 2019-2031
6.4.2.1. Brazil
6.4.2.2. Rest of Latin America

6.5. Middle East & Africa

6.5.1. Middle East & Africa Interventional Cardiology Devices Market revenue (US$ Million) by Technology, 2019-2031(US$ Million)
6.5.2. Middle East & Africa Interventional Cardiology Devices Market revenue (US$ Million) by country, (US$ Million) 2019-2031
6.5.2.1. South Africa
6.5.2.2. GCC Countries
6.5.2.3. Rest of MEA

Chapter 7. Competitive Landscape

7.1. Major Mergers and Acquisitions/Strategic Alliances
7.2. Company Profiles

7.2.1. Medtronic (US)
7.2.2. Boston Scientific Corporation (US)
7.2.3. Abbott (US)
7.2.4. Edward Lifescinces Corporation (US)
7.2.5. Cardinal Health (US)
7.2.6. iVascular (Spain)
7.2.7. Becton, Dickinson, and Company (US)
7.2.8. B. Braun Melsungen (Germany)
7.2.9. Terumo Corporation (Japan)
7.2.10. Biosensors International Group (Singapore)
7.2.11. BIOTRONIK SE & Co. KG (Germany).

Segmentation of Interventional Cardiology Devices Market- 

Interventional Cardiology Devices Market

Interventional Cardiology Devices Market Value (US$ Mn) and Volume (No. of Units) By Product

  • Angioplasty Balloons
    • Old/Normal Balloons
    • Drug-eluting Balloons
    • Cutting and Scoring Balloons
  • Angioplasty Stents
    • Drug-eluting Stents
    • Bare-metal Stents
    • Bioabsorbable Stents
  • Structural Heart Devics
    • Aortic Valve Therapy Devices
    • Other Therapy Devices (Mitral valve, pulmonary valve and tricuspid valve and left atrial appendage therapy devices)
  • Catheters
    • Angiography Catheters
    • Guiding Catheters
    • IVUS/OCT Catheters
  • Plaque Modification Devices
    • Atherectomy Devices
    • Thrombectomy Devices
  • Hemodynamic Flow Alteration Devices
    • Embolic Protection Devices
    • Chronic Total Occlusion Devices
  • Other Devices
    • Guidewires
    • Vascular Closure Devices
    • Introducer Sheaths
    • Hemostasis Valves
    • Balloon Inflation Devices

Interventional Cardiology Devices Market Value (US$ Mn) and Volume (No. of Units) By Region-

North America-

  • The US
  • Canada
  • Mexico

Europe-

  • Germany
  • The UK
  • France
  • Italy
  • Spain
  • Rest of Europe

Asia-Pacific-

  • China
  • Japan
  • India
  • South Korea
  • South East Asia
  • Rest of Asia Pacific

Latin America-

  • Brazil
  • Argentina
  • Rest of Latin America

Middle East & Africa-

  • GCC Countries
  • South Africa
  • Rest of Middle East and Africa

InsightAce Analytic follows a standard and comprehensive market research methodology focused on offering the most accurate and precise market insights. The methods followed for all our market research studies include three significant steps – primary research, secondary research, and data modeling and analysis - to derive the current market size and forecast it over the forecast period. In this study, these three steps were used iteratively to generate valid data points (minimum deviation), which were cross-validated through multiple approaches mentioned below in the data modeling section.

Through secondary research methods, information on the market under study, its peer, and the parent market was collected. This information was then entered into data models. The resulted data points and insights were then validated by primary participants.

Based on additional insights from these primary participants, more directional efforts were put into doing secondary research and optimize data models. This process was repeated till all data models used in the study produced similar results (with minimum deviation). This way, this iterative process was able to generate the most accurate market numbers and qualitative insights.

Secondary research

The secondary research sources that are typically mentioned to include, but are not limited to:

  • Company websites, financial reports, annual reports, investor presentations, broker reports, and SEC filings.
  • External and internal proprietary databases, regulatory databases, and relevant patent analysis
  • Statistical databases, National government documents, and market reports
  • Press releases, news articles, and webcasts specific to the companies operating in the market

The paid sources for secondary research like Factiva, OneSource, Hoovers, and Statista

Primary Research:

Primary research involves telephonic interviews, e-mail interactions, as well as face-to-face interviews for each market, category, segment, and subsegment across geographies

The contributors who typically take part in such a course include, but are not limited to: 

  • Industry participants: CEOs, CBO, CMO, VPs, marketing/ type managers, corporate strategy managers, and national sales managers, technical personnel, purchasing managers, resellers, and distributors.
  • Outside experts: Valuation experts, Investment bankers, research analysts specializing in specific markets
  • Key opinion leaders (KOLs) specializing in unique areas corresponding to various industry verticals
  • End-users: Vary mainly depending upon the market

Data Modeling and Analysis:

In the iterative process (mentioned above), data models received inputs from primary as well as secondary sources. But analysts working on these models were the key. They used their extensive knowledge and experience about industry and topic to make changes and fine-tuning these models as per the product/service under study.

The standard data models used while studying this market were the top-down and bottom-up approaches and the company shares analysis model. However, other methods were also used along with these – which were specific to the industry and product/service under study.

To know more about the research methodology used for this study, kindly contact us/click here.

user icon
office icon
mail icon
call icon

This website is secure, and we do not share your personal information with any third party. Privacy Policy

Need Customization
Need specific information/chapter from the report of the custom data table, graph or complete report? Tell us more.

Frequently Asked Questions

How big is the Interventional Cardiology Devices Market Size?

The Interventional Cardiology Devices Market Size is expected to grow at a 7.75% CAGR during the forecast period for 2024-2031.

Medtronic (US), Boston Scientific Corporation (US), Abbott (US), Edward Lifescinces Corporation (US), Cardinal Health (US), iVascular (Spain), Becton,

Our Clients

  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo

Media Citations

  • media citation logo
  • media citation logo
  • media citation logo
  • media citation logo
  • media citation logo
  • media citation logo
  • media citation logo
  • media citation logo
  • media citation logo

Growth opportunities and latent adjacency in Medical Devices

Select Licence Type
$4456
$7786
$10000
$1200
Get Your GTM Strategy

Navigate market entry with channel selection, launch strategy & timeline, and pricing model support.

Equip yourself with the insights needed to develop a winning go-to-market strategy

Get real-time updates and joint control over project direction with our collaborative approach